WALNUT CREEK,Calif.--The US Department of Energy's Joint Genome Institute has purchased an additional 60 MegaBace 1000 high-throughput DNA sequencers from Amersham Pharmacia Biotech, Nycomed Amersham's life science business. This acquisition brings the number of MegaBace sequencers in operation at the institute to 86. Trevor Hawkins, the institute's director of sequencing, said, "Since our initial order was installed in June, we have been extremely impressed with the results and performance of MegaBace."
Joint Genome Institute Buys 60 More Sequencing Machines from Amersham
Aug 27, 1999